Psoriasis: Biologics bring potential for long-term remission off treatmentOctober 22, 2017PsoriasisPsoriatic Arthritis
High ‘nocebo’ effect observed when patients knowingly switch to a biosimilarOctober 18, 2017Psoriatic Arthritis
Pediatric psoriasis carries sharply increased risk of selected autoimmune comorbiditiesOctober 14, 2017PsoriasisPsoriatic Arthritis
Biologic approved for moderate to severe psoriasis in adolescentsOctober 14, 2017PsoriasisPsoriatic Arthritis
TNF inhibitors associated with fewer side effects than methotrexate in children with psoriasisSeptember 30, 2017PsoriasisPsoriatic Arthritis
Swedish study finds low risk of developing psoriasis in bariatric surgery patientsSeptember 29, 2017PsoriasisPsoriatic Arthritis
Adjuvant-boosted shingles vaccine earns FDA panel’s unanimous nodSeptember 13, 2017Psoriatic Arthritis
FDA approves second adalimumab biosimilar for multiple conditionsAugust 28, 2017Psoriatic ArthritisPsoriasis
Noninvasive NASH test could help monitor hepatotoxicity in patients on methotrexateAugust 24, 2017PsoriasisPsoriatic Arthritis